Literature DB >> 7045197

Idiopathic portal hypertension in a renal transplant recipient.

J E Bredfeldt, R E Enriquez, R J Groszmann.   

Abstract

A renal transplant recipient developed a noncirrhotic form of portal hypertension, idiopathic portal hypertension, several years after the transplantation. The liver histology by light microscopy disclosed only chronic portal inflammation and portal fibrosis; however, a prominent collagen deposition with the space of Disse seen only by electron microscopy evolved during the course of the liver disease. This report, in association with other reports of the same disorder in renal transplant recipients, suggests that idiopathic portal hypertension may occur as a direct consequence of renal transplantation.

Entities:  

Mesh:

Year:  1982        PMID: 7045197     DOI: 10.1097/00004836-198204000-00012

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  4 in total

1.  A case of idiopathic portal hypertension after renal transplantation.

Authors:  N Yanagisawa; H Sugaya; K Yunomura; T Harada; T Hisauchi
Journal:  Gastroenterol Jpn       Date:  1990-10

2.  Peliosis hepatis induced by 6-thioguanine administration.

Authors:  D Larrey; E Fréneaux; A Berson; G Babany; C Degott; D Valla; D Pessayre; J P Benhamou
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

3.  Idiopathic portal hypertension in renal transplant recipients: report of two cases.

Authors:  N Yoshimura; T Oka; Y Ohmori; T Yasumura; H Kohnosu; T Kobashi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

4.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.